M&A

News

Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn

Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.4 bn, setting up one of the largest private equity buyouts in Japan's health sector.

News

Liva buys Momenta to bolster digital health platform

Liva Healthcare has acquired Momenta to create one of the largest providers of digital healthy lifestyle services to the NHS in England.

News

Troubled 23andMe is exploring a sale of the business

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.

News

Sage rejects Biogen takeover and launches review

Sage Therapeutics has unanimously rejected Biogen's acquisition offer of around $469 million, saying it "significantly undervalues" the company.

R&D

5 takeaways from JP Morgan 2025

I’m back from another week in San Francisco, where as usual I heard from experts and prognosticators about their expectations for the coming year in biotech.

News

Sun Pharma, Taro Pharma, and Antibe Therapeutics logos

Sun Pharma unit poised to buy Canadian biotech Antibe

Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and inflammation.

Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn

Liva buys Momenta to bolster digital health platform

Troubled 23andMe is exploring a sale of the business

Sage rejects Biogen takeover and launches review

5 takeaways from JP Morgan 2025

Sun Pharma unit poised to buy Canadian biotech Antibe

NHS use of Incyte's anal cancer drug Zynyz backed by NICE

Securing your ROI: Turning post-acquisition integration into...

M&A

Editor's Picks